Henning Lauterbach

Affiliations: 
2005-2007 Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Google:
"Henning Lauterbach"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Purde MT, Cupovic J, Palmowski YA, et al. (2023) A replicating LCMV-based vaccine for the treatment of solid tumors. Molecular Therapy : the Journal of the American Society of Gene Therapy
Boopathy AV, Sharma B, Nekkalapudi A, et al. (2023) Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys. Npj Vaccines. 8: 175
Schmidt S, Mengistu M, Daffis S, et al. (2023) Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive HBV-specific CD8 T cell responses and high anti-HBs titers. The Journal of Infectious Diseases
Hinterberger M, Endt K, Bathke B, et al. (2023) Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication. Scientific Reports. 13: 5162
Lauterbach H, Schmidt S, Katchar K, et al. (2021) Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform. Frontiers in Oncology. 11: 732166
Stutte S, Ruf J, Kugler I, et al. (2021) Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice. Brain, Behavior, and Immunity
Hinterberger M, Giessel R, Fiore G, et al. (2021) Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal For Immunotherapy of Cancer. 9
Schmidt S, Bonilla WV, Reiter A, et al. (2020) Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer. Oncoimmunology. 9: 1809960
Raguz J, Schmidt S, Kleisner T, et al. (2020) Abstract 4058: TheraT - a highly versatile arenavirus based vector platform for intravenous and intratumoral cancer immunotherapy Cancer Research. 80: 4058-4058
Hinterberger M, Medina-Echeverz J, Testori M, et al. (2020) P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies Journal For Immunotherapy of Cancer. 8: A37.1-A37
See more...